Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial
Carregando...
Citações na Scopus
29
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
EUROPA EDITION
Autores
ONUMA, Yoshinobu
SOTOMI, Yohei
COLLET, Carlos
THOMSEN, Brian
ROGERS, Campbell
ZENG, Yaping
TENEKECIOGLU, Erhan
ASANO, Taku
MIYASAKI, Yosuke
Citação
EUROINTERVENTION, v.12, n.16, p.2001-2008, 2017
Resumo
Aims: The aim of this study was to investigate whether a Heart Team decision-making process regarding the choice of revascularisation strategy based on non-invasive coronary multislice computed tomography angiography (MSCT) assessment of coronary artery disease (CAD) is equivalent to the standard-of-care invasive angiography-based assessment in patients with multivessel CAD. Methods and results: The SYNTAX III Revolution trial is a prospective, multicentre, all-comers randomised trial that will randomise two Heart Teams to select between surgical and percutaneous treatment according to either an invasive conventional angiography or a non-invasive MSCT angiography assessment in patients with multivessel CAL). The treatment selection by each Hean Team will be guided by the SYNTAX score II calculation. The primary endpoint is the level of agreement according to kappa of the initial decision by die Heart Teams on the modality of the rcvascularisation based on MSCT and angiography assessments. Secondary endpoints include agreement on the number of vessels requiring treatment and the coronary segments in need of revascularisation. Conclusions: The SYNTAX III Revolution trial will provide valuable information regarding the ability of a purely non-invasive coronary anatomy assessment to select accurately the most appropriate revascularisation strategy for patients with multivessel CAD.
Palavras-chave
coronary artery bypass graft, coronary computed tomography angiography, Heart Team, multivessel coronary disease, percutaneous coronary intervention
Referências
- Bittencourt MS, 2014, CIRC-CARDIOVASC IMAG, V7, P282, DOI 10.1161/CIRCIMAGING.113.001047
- Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031
- Campos CM, 2015, CATHETER CARDIO INTE, V86, pE229, DOI 10.1002/ccd.25907
- Chieffo A, 2012, JACC-CARDIOVASC INTE, V5, P718, DOI 10.1016/j.jcin.2012.03.022
- Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516
- Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7
- Farooq V, 2012, EUR HEART J, V33, P3105, DOI 10.1093/eurheartj/ehs367
- Garg S, 2011, JACC-CARDIOVASC INTE, V4, P432, DOI 10.1016/j.jcin.2011.01.008
- GRUNTZIG A, 1978, LANCET, V1, P263
- Head SJ, 2013, EUR HEART J, V34, P2862, DOI 10.1093/eurheartj/eht330
- Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009
- Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213
- LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
- Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622
- McDaniel MC, 2011, JACC-CARDIOVASC INTE, V4, P1155, DOI 10.1016/j.jcin.2011.07.013
- Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5
- Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689
- Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211
- Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020
- Nieman K, 2002, CIRCULATION, V106, P2051, DOI 10.1161/01.CIR.0000037222.58317.3D
- Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017
- Papadopoulou SL, 2013, JACC-CARDIOVASC IMAG, V6, P413, DOI 10.1016/j.jcmg.2012.09.013
- Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
- Pijls NH, 2010, J AM COLL CARDIOL, V56, P177
- Raju R, 2016, CLIN IMAG, V40, P205, DOI 10.1016/j.clinimag.2015.10.009
- Senuys PW, 2009, EUROINTERVENTION, V5, P50
- Serruys PW, 2012, JACC-CARDIOVASC INTE, V5, P606, DOI 10.1016/j.jcin.2012.03.016
- Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
- Sianos Georgios, 2005, EuroIntervention, V1, P219
- Sim J, 2005, PHYS THER, V85, P257
- Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
- Valgimigli M, 2007, AM J CARDIOL, V99, P1072, DOI 10.1016/j.amjcard.2006.11.062
- Windecker S, 2014, EUR HEART J, V35, P2541, DOI 10.1093/eurheartj/ehu278
- Wykrzykowska JJ, 2010, J AM COLL CARDIOL, V56, P272, DOI 10.1016/j.jacc.2010.03.044